ERRATUM: Simvastatin profoundly impairs energy metabolism in primary human muscle cells

in Endocrine Connections
View More View Less
  • 1 Minerva Foundation Institute for Medical Research, Helsinki, Finland
  • | 2 Department of Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland
  • | 3 Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland

Contributor Notes

Correspondence should be addressed to H A Koistinen: heikki.koistinen@helsinki.fi
Open access

The authors and journal apologize for an error in the above paper, which appeared in volume 9, part 11, pages 1103–1113. The error relates to Fig. 3 given on page 1108.

Figure 3
Figure 3

Glycolysis and glycolytic capacity in response to pre-exposure to lactone- and acid-form simvastatin were measured by detecting extracellular acidification rate (ECAR) in primary human myoblasts with Seahorse analyzer. Data (in mpH/min/20,000 cells) are expressed as mean ± s.e.m. from six men. ***P < 0.001 vs respective control, one-way ANOVA with repeated measurements, Sidak’s post hoc test.

Citation: Endocrine Connections 11, 7; 10.1530/EC-20-0444e

In the original figure artwork, ‘Glycolysis’ and ‘Glycolytic capacity’ were transposed in the key of the upper panel.

The correct Figure appears in full below:

 

     European Society of Endocrinology logo

     Society for Endocrinology logo

  • View in gallery

    Glycolysis and glycolytic capacity in response to pre-exposure to lactone- and acid-form simvastatin were measured by detecting extracellular acidification rate (ECAR) in primary human myoblasts with Seahorse analyzer. Data (in mpH/min/20,000 cells) are expressed as mean ± s.e.m. from six men. ***P < 0.001 vs respective control, one-way ANOVA with repeated measurements, Sidak’s post hoc test.